Amlodipine and vascular hypertrophy

International Journal of Cardiology

Volumn 62, Issue SUPPL. 2, 1997, Pages

  Stepien, Olivier ^a   Iouzalen, Lahcen ^a   Herembert, Thierry ^a   Zhu, Ding Liang ^b   Marche, Pierre ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Shanghai Institute of Hypertension   (China)

Author keywords

Atherosclerosis; Cell cycle; DNA synthesis; Hypertension; Proliferation; Vascular smooth muscle cells

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BASIC FIBROBLAST GROWTH FACTOR; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CYCLE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENDOTHELIUM CELL; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL COUNT; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; DNA; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; HYPERTENSION; HYPERTROPHY; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0031593128     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00244-1     Document Type: Conference Paper

References (37)

1. Mulvany M.J., Hansen P.K., Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 43:1978;854-864.
2. Owens G.K., Schwartz S.M. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploïdy and hyperplasia. Circ Res. 51:1982;280-289.
3. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 62:1982;347-504.
4. Campbell JH, Black MJ, Campbell GR, Replication of smooth muscle cells in atherosclerosis and hypertension. In Meyer P, Marche P, editors. Blood cells and arteries in hypertension and atherosclerosis. Atherosclerosis reviews. New York: Raven Press, 1989;19:15-33.
5. Marche P., Hérembert T., Zhu D.L. Molecular mechanisms of vascular hypertrophy in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 22(Suppl 1):1995;S114-S116.
6. Yamori Y., Igawa T., Kanbe T., Kihara M., Nara Y., Horie R. Mechanisms of structural vascular changes in genetic hypertension: analyses on cultured vascular smooth muscle cells from spontaneously hypertensive rats. Clin Sci. 61:1981;121s-123s.
7. Scott-Burden T., Schini V.B., Elizondo E., Junquero D.C., Vanhoutte P.M. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circ Res. 71:1992;1088-1100.
8. 1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension. Am J Physiol. 263:1992;C420-C428.
9. Lindner V., Lappi D.A., Baird A., Majack R.A., Reidy M.A. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 68:1991;106-113.
10. Zhu D.L., Hérembert T., Caruelle D., Caruelle J.P., Marche P. Signaling mechanisms of basic fibroblast growth factor in arterial cells from genetically hypertensive rat. Am J Hypertens. 7:1994;351-356.
11. Mogami H., Kojima I. Stimulation of calcium entry is a prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun. 196:1993;650-658.
12. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA. 90:1993;4986-4990.
13. Jackson C.L., Schwartz S.M. Pharmacology of smooth muscle cell replication. Hypertension. 20:1992;713-736.
14. Zhu D.L., Hérembert T., Caruelle D., Caruelle J.P., Marche P. Involvement of calcium channels in fibroblast growth factor-induced activation of arterial cells in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 23:1994;395-400.
15. Hérembert T., Zhu D.L., Marche P. Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats. Br J Pharmacol. 114:1995;1703-1709.
16. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 50:1971;172-176.
17. Gogusev J., Zhu D.L., Hérembert T., Ammarguellat F., Marche P., Drüeke T. Effect of erythropoïetin on DNA synthesis, proto-oncogene expression and phospholipase C activity in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 199:1994;977-983.
18. Ashihara T., Baserga R. Cell synchronization. Methods Enzymol. 58:1979;248-262.
19. Uehara Y., Kawabata Y., Hirawa N.et al. OPC-13340, a new dihydropyridine calcium channel blocker, attenuates rapid vascular smooth muscle cell growth in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 20:1992;408-415.
20. Kueng W., Silber F., Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem. 182:1989;16-19.
21. Zhu D.L., Hérembert T., Marche P. Increased proliferation of adventitial fibroblasts from spontaneously hypertensive rat aorta. J Hypertens. 9:1991;1161-1168.
22. Nilsson J., Sjölund M., Pamberg L., Euler A.M., Von Jonzon B., Thyberg J. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis. 68:1985;109-122.
23. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci USA. 86:1989;2388-2392.
24. Ko Y., Totzke G., Graack G.H.et al. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J Hypertens. 11:1993;1171-1178.
25. 2+-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci USA. 88:1991;9041-9045.
26. Shultz P.J., Raij L. Effect of amlodipine on mesangial cell proliferation and protein synthesis. Am J Hypertens. 5:1992;912-914.
27. 2+ channel interaction. Trends Pharmacol Sci. 11:1990;38-44.
28. Scott-Burden T., Resink T.J., Bühler F.R. Enhanced growth and growth factor responsiveness of vascular smooth muscle cells from hypertensive rats. J Cardiovasc Pharmacol. 14(Suppl 6):1989;S16-S21.
29. Agrotis A., Saltis J., Bobik A. Transforming growth factor-b1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 23:1994;593-599.
30. Morel N., Godfraind T. Selective interaction of the calcium antagonist amlodipine with calcium channel in arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 24:1994;524-533.
31. Nayler W.G. The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. J Cardiovasc Pharmacol. 12(Suppl 7):1988;S41-S44.
32. Nayler WG, Calcium antagonists and the treatment of hypertension. In: Nayler WG, editor. Amlodipine. Berlin: Springer-Verlag, 1993:148-176.
33. Tulenko T.N., Chen M., Stepp D.W.et al. The actions of the charged dihydropyridine, amlodipine (Norvasc), in a cell culture model of dietary atherosclerosis. J Cardiovasc Pharmacol. 26(Suppl A):1995;S11-S17.
34. McMurray H.F., Chahwala S.B. Amlodipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture. J Cardiovasc Pharmacol. 20(Suppl A):1992;S54-S56.
35. 2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA. 93:1996;5478-5482.
36. Holzgreve H., Bürkle B. Anti-atherosclerotic effects of calcium antagonists. J Hypertension. 11(Suppl 1):1993;S55-S59.
37. Nayler WG. The antiatherogenic potential of the calcium antagonists, including amlodipine. In: Nayler WG, editor. Amlodipine. Berlin: Springer-Verlag, 1993:178-198.